Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.417ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.417ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AM.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AM.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AM.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AM.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AM.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AM.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AM.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AM.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.258.20EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.258.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258.20ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.258.20ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.258.20EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.258.20EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.258.20ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.258.20ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.37EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.36.37EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.37ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.36.37ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.36.37EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.36.37EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.36.37ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.36.37ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.319EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.319EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.319ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.319ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.319EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.319EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.319ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.319ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.504EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.504EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
B.1.504ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-2824.15Germany
B.1.504ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-3196.01Germany
B.1.504EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-3064.43China
B.1.504EHuang-EGCAGCAGTACGCACACAATC20552637626357R-3384China
B.1.504ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
B.1.504ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20103.9China
AE.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AE.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AE.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AE.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AE.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AE.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AE.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AE.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used